Contact this trialFirst, we need to learn more about you.
Integrase Inhibitor
Injectable Cabotegravir for HIV Prevention
Recruiting0 awardsPhase 2 & 3
Atlanta, Georgia
This trial will test whether the injectable drug cabotegravir is safe and effective for preventing HIV in cisgender men who have sex with men and transgender women who have sex with men.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service